Cervical cancer

Each year, more than half a million women are diagnosed with cervical cancer and the disease results in over 300 000 deaths worldwide. High-risk subtypes of the human papilloma virus (HPV) are the cause of the disease in most cases. The disease is largely preventable. Approximately 90% of cervical c...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	The Lancet (British edition) Ročník 393; číslo 10167; s. 169 - 182
Hlavní autori:	Cohen, Paul A, Jhingran, Anjua, Oaknin, Ana, Denny, Lynette
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England Elsevier Ltd 12.01.2019 Elsevier Limited
Predmet:	Bevacizumab Cancer Cervical cancer Cervix Chemoradiotherapy Female Fertility Global Health Health risk assessment Healthcare Disparities - statistics & numerical data HIV Human immunodeficiency virus Human papillomavirus Humans Hysterectomy Immunotherapy Incidence Income Mass Screening - methods Mass Screening - statistics & numerical data Metastases Monoclonal antibodies Mortality Neoplasm Staging Papillomavirus Infections - epidemiology Papillomavirus Vaccines - immunology Poverty Radiation therapy Risk Factors Screening Solid tumors Targeted cancer therapy Toxicity Uterine Cervical Neoplasms - diagnosis Uterine Cervical Neoplasms - epidemiology Uterine Cervical Neoplasms - prevention & control Uterine Cervical Neoplasms - therapy Vaccination Vaccines Vascular endothelial growth factor Viruses Womens health United States > US South Africa Africa
ISSN:	0140-6736, 1474-547X, 1474-547X
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!